17 research outputs found
Stereocomplementary Bioreduction of β‑Ketonitrile without Ethylated Byproduct
α-Ethylation is competing with the biocatalytic reduction of aromatic β-ketonitriles in a whole-cell system. Use of two newly mined robust and stereocomplementary carbonyl reductases in a biphasic system has completely eliminated the competing byproduct. For the first time, both enantiomers of fluoroxetine precursors were obtained at 0.5 M with >99% <i>ee</i> and excellent chemoselectivity, without addition of any external cofactors
Molecular Dynamics Investigation of the Substrate Binding Mechanism in Carboxylesterase
A recombinant carboxylesterase, cloned
from <i>Pseudomonas
putida</i> and designated as rPPE, is capable of catalyzing the
bioresolution of racemic 2-acetoxy-2-(2′-chlorophenyl)Âacetate
(<i>rac</i>-AcO-CPA) with excellent (<i>S</i>)-enantioselectivity.
Semirational design of the enzyme showed that the W187H variant could
increase the activity by ∼100-fold compared to the wild type
(WT) enzyme. In this study, we performed all-atom molecular dynamics
(MD) simulations of both apo-rPPE and rPPE in complex with (<i>S</i>)-AcO-CPA to gain insights into the origin of the increased
catalysis in the W187H mutant. Our results show differential binding
of (<i>S</i>)-AcO-CPA in the WT and W187H enzymes, especially
the interactions of the substrate with the two active site residues
Ser159 and His286. The replacement of Trp187 by His leads to considerable
structural rearrangement in the active site of W187H. Unlike in the
WT rPPE, the cap domain in the W187 mutant shows an open conformation
in the simulations of both apo and substrate-bound enzymes. This open
conformation exposes the catalytic triad to the solvent through a
water accessible channel, which may facilitate the entry of the substrate
and/or the exit of the product. Binding free energy calculations confirmed
that the substrate binds more strongly in W187H than in WT. On the
basis of these computational results, we further predicted that the
mutations W187Y and D287G might also be able to increase the substrate
binding and thus improve the enzyme’s catalytic efficiency.
Experimental binding and kinetic assays on W187Y and D287G show improved
catalytic efficiency over WT, but not W187H. Contrary to our prediction,
W187Y shows slightly decreased substrate binding coupled with a 100-fold
increase in turnover rate, while in D287G the substrate binding is
8 times stronger but with a slightly reduced turnover rate. Our work
provides important molecular-level insights into the binding of the
(<i>S</i>)-AcO-CPA substrate to carboxylesterase rPPEs,
which will help guide future development of more efficient rPPE variants
Access to Optically Active Aryl Halohydrins Using a Substrate-Tolerant Carbonyl Reductase Discovered from Kluyveromyces thermotolerans
By genome data mining, a carbonyl reductase tool box
was designed
and developed for chiral alcohol synthesis. On the basis of systematic
comparison of the specific activity and substrate tolerance toward
α-chloroacetophenone among reductases in this tool box, KtCR,
a highly substrate-/product-tolerant carbonyl reductase from Kluyveromyces thermotolerans, was identified. The
reduction of a series of substituted aryl ketones was investigated
using this newly mined biocatalyst. Almost all of the ketones tested
were asymmetrically reduced into corresponding chiral alcohols in
99% ee. Substrates with substituents adjacent to the carbonyl group
or those with substituents on the para position of the phenyl ring
were easier to reduce. For α-choloacetophenone as a representative
substrate, as much as 154 g/L (1.0 M) of the substrate was asymmetrically
reduced within merely 12 h by lyophilized cells of Escherichia coli/pET28-KtCR, resulting in an isolated
yield of 92%, an enantiopurity of >99% ee, and a total turnover
number
of 5000, which was five times higher than the highest record reported
so far. These results indicate the great potential of KtCR in practical
synthesis of valuable aryl halohydrins as versatile chiral synthons
Identification of an Imine Reductase for Asymmetric Reduction of Bulky Dihydroisoquinolines
A new imine reductase from <i>Stackebrandtia nassauensis</i> (<i>Sn</i>IR) was identified,
which displayed over 25-
to 1400-fold greater catalytic efficiency for 1-methyl-3,4-dihydroÂisoquinoline
(1-Me DHIQ) compared to other imine reductases reported. Subsequently,
an efficient <i>Sn</i>IR-catalyzed process was developed
by simply optimizing the amount of cosolvent, and up to 15 g L<sup>–1</sup> 1-Me DHIQ was converted completely without a feeding
strategy. Furthermore, the reaction proceeded well for a panel of
dihydroisoquinolines, affording the corresponding tetrahydroisoquinolines
(mostly in <i>S</i>-configuration) in good yields (up to
81%) and with moderate to excellent enantioselectivities (up to 99%
ee)
BoletÃn de Segovia: Número 103 - 1893 agosto 28
Copia digital. Madrid : Ministerio de Cultura. Subdirección General de Coordinación Bibliotecaria, 200
Highly Efficient Synthesis of (<i>R</i>)‑3-Quinuclidinol in a Space–Time Yield of 916 g L<sup>–1</sup> d<sup>–1</sup> Using a New Bacterial Reductase <i>Ar</i>QR
A new keto reductase (<i>Ar</i>QR), identified from <i>Agrobacterium radiobacter</i> ECU2556, can efficiently reduce 3-quinuclidinone in excellent enantioselectivity and high space–time yield for the synthesis of (<i>R</i>)-3-quinuclidinol, a chiral building block of many antimuscarinic agents. This is the first time that a high yield of (<i>R</i>)-3-quinuclidinol up to 916 g L<sup>–1</sup> d<sup>–1</sup> using a bioreduction approach is reported
MOESM1 of Marked enhancement of Acinetobacter sp. organophosphorus hydrolase activity by a single residue substitution Ile211Ala
Additional file 1. In the Supplemental Material Section results from the crystallization of the purified AbOPH protein and selection of the mutational amino acids as well as the activities comparison of AbOPH with its variants are presented
Efficient Degradation of Malathion in the Presence of Detergents Using an Engineered Organophosphorus Hydrolase Highly Expressed by <i>Pichia pastoris</i> without Methanol Induction
The biodegradation of pesticides
by organophosphorus hydrolases
(OPHs) requires an efficient enzyme production technology in industry.
Herein, a <i>Pichia pastoris</i> strain was constructed
for the extracellular expression of <i>Po</i>OPH<sub>M9</sub>, an engineered malathion-degrading enzyme. After optimization, the
maximum titer and yield of fermentation reached 50.8 kU/L and 4.1
g<sub>protein</sub>/L after 3 days, with the highest space-time yield
(STY) reported so far, 640 U L<sup>–1</sup> h<sup>–1</sup>. <i>Po</i>OPH<sub>M9</sub> displayed its high activity
and stability in the presence of 0.1% (w/w) plant-derived detergent.
Only 0.04 mg/mL enzyme could completely remove 0.15 mM malathion in
aqueous solution within 20 min. Furthermore, 12 μmol malathion
on apples and cucumbers surfaces was completely removed by 0.05 mg/mL <i>Po</i>OPH<sub>M9</sub> in tap water after 35 min washing. The
efficient production of the highly active <i>Po</i>OPH<sub>M9</sub> has cleared a major barrier to biodegradation of pesticide
residues in food industry
Dramatically Improved Performance of an Esterase for Cilastatin Synthesis by Cap Domain Engineering
Whole-protein
random mutation and substrate tunnel evolution have
recently been applied to the pharmaceutically relevant esterase <i>Rh</i>Est1 for the synthesis of a cilastatin precursor. The
mutant <i>Rh</i>Est1<sub>M1</sub> (=<i>Rh</i>Est1<sub>A147I/V148F/G254A</sub>) was identified from a large library consisting
of 1.5 × 10<sup>4</sup> variants. Though the activity of this
mutant was improved 5-fold, the enantioselectivity for biohydrolysis
decreased at the same time. Herein a smart library (3.0 × 10<sup>3</sup>) focused on the cap domain of <i>Rh</i>Est1 was
constructed to improve its catalytic performance comprehensively.
As a result, a variant designated as <i>Rh</i>Est1<sub>M2</sub> (=<i>Rh</i>Est1<sub>M1‑A143T</sub>), showed a 6-fold
increase in specific activity compared with the wild type. Meanwhile,
the decreased enantioselectivity for enzymatic resolution was recovered
to the native enzyme level. The melting temperature of <i>Rh</i>Est1<sub>M2</sub> was nearly 11 °C higher than that of the wild
type. This work provides detailed insight into the vital role of α/β
hydrolase cap domains in influencing all aspects of enzyme characteristics.
Furthermore, the commercial resin ESR-1 with free amino groups was
used for enzyme immobilization to enhance the operational performance
of <i>Rh</i>Est1<sub>M2</sub>. No obvious activity loss
was observed when the immobilized enzyme was incubated at 30 °C
for 200 h. The immobilized enzyme could be repeatedly used for up
to 20 batches, and the total turnover number (TTN) reached up to 8.0
× 10<sup>5</sup>
Increased Catalyst Productivity in α‑Hydroxy Acids Resolution by Esterase Mutation and Substrate Modification
Optically pure α-hydroxy acids
and their derivatives are
versatile chiral building blocks in the pharmaceutical industry. In
this study, the potential of a recombinant Pseudomonas
putida esterase (rPPE01) for the enzymatic resolution
of α-acetoxy acids was significantly improved by combinatorial
engineering of both the biocatalyst and substrate. Semirational design
based on homologous modeling and molecular docking provided a single-point
variant, W187H, whose <i>k</i><sub>cat</sub>/<i>K</i><sub>M</sub> for sodium 2-acetoxy-2-(2′-chlorophenyl)Âacetate
(Ac-CPA-Na) was increased 100-fold, from 0.0611 to 6.20 mM<sup>–1</sup> s<sup>–1</sup>, while retaining its excellent enantioselectivity
and broad substrate spectrum. Biocatalyst deactivation under the operating
conditions was decreased by using the potassium salt of Ac-CPA instead
of Ac-CPA-Na. With 0.5 g L<sup>–1</sup> of lyophilized cells
containing rPPE01-W187H, 500 mM (<i>R</i>,<i>S</i>)-Ac-CPA-K was selectively deacylated with 49.9% conversion within
15 h, giving satisfactory enantiomeric excesses (ee) for both the <i>S</i> product (>99% ee) and the remaining <i>R</i> substrate (98.7% ee). Consequently, the amount of (<i>S</i>)-2-hydroxy-2-(2′-chlorophenyl)Âacetate prepared per unit weight
of lyophilized cells was improved by a factor of 18.9 compared with
the original productivity of the wild-type esterase. Further enzymatic
resolution of other important hydroxy acids at the 100 mL scale demonstrated
that the rPPE01-W187H-based bioprocess is versatile and practical
for the large-scale preparation of chiral α-hydroxy acids